LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

Acyl-CoA_dehydrogenase_putative/GeneDB:LmjF.28.25 10

Quick info Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
Acyl-CoA_dehydrogenase_putative/GeneDB:LmjF.28.25 10
Gene product:
acyl-CoA dehydrogenase, putative
Species:
Leishmania donovani
UniProt:
A0A3Q8IIB9_LEIDO
TriTrypDb:
LdBPK_282700.1 , LdCL_280032100 , LDHU3_28.3650
Length:
629

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. yes yes: 25
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. yes yes: 8
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 12
NetGPI no yes: 0, no: 12
Cellular components
Term Name Level Count
GO:0005737 cytoplasm 2 1
GO:0110165 cellular anatomical entity 1 3
GO:0016020 membrane 2 2

Expansion

Sequence features

A0A3Q8IIB9
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: A0A3Q8IIB9

Function

Could not find GO biological_process term for this entry.
Molecular functions
Term Name Level Count
GO:0000166 nucleotide binding 3 13
GO:0003824 catalytic activity 1 13
GO:0005488 binding 1 13
GO:0016491 oxidoreductase activity 2 13
GO:0016627 oxidoreductase activity, acting on the CH-CH group of donors 3 13
GO:0036094 small molecule binding 2 13
GO:0043167 ion binding 2 13
GO:0043168 anion binding 3 13
GO:0050660 flavin adenine dinucleotide binding 4 13
GO:0097159 organic cyclic compound binding 2 13
GO:1901265 nucleoside phosphate binding 3 13
GO:1901363 heterocyclic compound binding 2 13
GO:0003995 acyl-CoA dehydrogenase activity 5 5
GO:0016628 oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor 4 5
GO:0043958 acryloyl-CoA reductase (NADH) activity 5 5
GO:0052890 oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor 4 5

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_C14_Caspase3-7 233 237 PF00656 0.513
CLV_C14_Caspase3-7 65 69 PF00656 0.615
CLV_C14_Caspase3-7 87 91 PF00656 0.533
CLV_NRD_NRD_1 3 5 PF00675 0.640
CLV_NRD_NRD_1 350 352 PF00675 0.493
CLV_NRD_NRD_1 482 484 PF00675 0.410
CLV_NRD_NRD_1 610 612 PF00675 0.429
CLV_PCSK_FUR_1 348 352 PF00082 0.524
CLV_PCSK_KEX2_1 3 5 PF00082 0.649
CLV_PCSK_KEX2_1 350 352 PF00082 0.524
CLV_PCSK_KEX2_1 495 497 PF00082 0.640
CLV_PCSK_KEX2_1 499 501 PF00082 0.617
CLV_PCSK_KEX2_1 610 612 PF00082 0.546
CLV_PCSK_PC1ET2_1 495 497 PF00082 0.640
CLV_PCSK_PC1ET2_1 499 501 PF00082 0.617
CLV_PCSK_SKI1_1 22 26 PF00082 0.605
CLV_PCSK_SKI1_1 315 319 PF00082 0.415
CLV_PCSK_SKI1_1 390 394 PF00082 0.492
CLV_PCSK_SKI1_1 483 487 PF00082 0.535
CLV_PCSK_SKI1_1 530 534 PF00082 0.492
DEG_APCC_DBOX_1 389 397 PF00400 0.492
DEG_APCC_DBOX_1 534 542 PF00400 0.468
DEG_Nend_Nbox_1 1 3 PF02207 0.663
DOC_CKS1_1 101 106 PF01111 0.470
DOC_CKS1_1 421 426 PF01111 0.410
DOC_PP1_RVXF_1 29 36 PF00149 0.418
DOC_PP4_FxxP_1 259 262 PF00568 0.397
DOC_PP4_FxxP_1 421 424 PF00568 0.410
DOC_USP7_MATH_1 20 24 PF00917 0.676
DOC_USP7_MATH_1 209 213 PF00917 0.541
DOC_USP7_MATH_1 547 551 PF00917 0.542
DOC_USP7_MATH_1 55 59 PF00917 0.773
DOC_USP7_MATH_1 9 13 PF00917 0.717
DOC_USP7_UBL2_3 286 290 PF12436 0.426
DOC_USP7_UBL2_3 48 52 PF12436 0.635
DOC_USP7_UBL2_3 495 499 PF12436 0.645
DOC_WW_Pin1_4 100 105 PF00397 0.477
DOC_WW_Pin1_4 420 425 PF00397 0.410
LIG_14-3-3_CanoR_1 164 170 PF00244 0.448
LIG_14-3-3_CanoR_1 22 27 PF00244 0.521
LIG_14-3-3_CanoR_1 245 251 PF00244 0.507
LIG_14-3-3_CanoR_1 350 354 PF00244 0.492
LIG_14-3-3_CanoR_1 530 539 PF00244 0.450
LIG_BIR_III_4 583 587 PF00653 0.546
LIG_BRCT_BRCA1_1 135 139 PF00533 0.426
LIG_BRCT_BRCA1_1 550 554 PF00533 0.492
LIG_CaM_IQ_9 522 537 PF13499 0.410
LIG_FHA_1 16 22 PF00498 0.575
LIG_FHA_1 188 194 PF00498 0.465
LIG_FHA_1 233 239 PF00498 0.438
LIG_FHA_1 251 257 PF00498 0.277
LIG_FHA_1 292 298 PF00498 0.444
LIG_FHA_1 470 476 PF00498 0.402
LIG_FHA_1 510 516 PF00498 0.546
LIG_FHA_1 531 537 PF00498 0.492
LIG_FHA_1 598 604 PF00498 0.492
LIG_FHA_1 61 67 PF00498 0.559
LIG_FHA_2 138 144 PF00498 0.465
LIG_FHA_2 205 211 PF00498 0.410
LIG_FHA_2 465 471 PF00498 0.410
LIG_FHA_2 588 594 PF00498 0.482
LIG_LIR_Apic_2 257 262 PF02991 0.397
LIG_LIR_Apic_2 418 424 PF02991 0.410
LIG_LIR_Gen_1 109 116 PF02991 0.513
LIG_LIR_Gen_1 558 568 PF02991 0.426
LIG_LIR_Gen_1 596 606 PF02991 0.482
LIG_LIR_Nem_3 109 114 PF02991 0.374
LIG_LIR_Nem_3 153 158 PF02991 0.444
LIG_LIR_Nem_3 38 44 PF02991 0.453
LIG_LIR_Nem_3 45 50 PF02991 0.487
LIG_LIR_Nem_3 551 557 PF02991 0.436
LIG_LIR_Nem_3 558 563 PF02991 0.387
LIG_LIR_Nem_3 596 602 PF02991 0.495
LIG_LIR_Nem_3 81 86 PF02991 0.540
LIG_Rb_pABgroove_1 38 46 PF01858 0.543
LIG_SH2_CRK 111 115 PF00017 0.465
LIG_SH2_CRK 155 159 PF00017 0.519
LIG_SH2_CRK 422 426 PF00017 0.397
LIG_SH2_CRK 47 51 PF00017 0.552
LIG_SH2_CRK 560 564 PF00017 0.524
LIG_SH2_NCK_1 37 41 PF00017 0.547
LIG_SH2_NCK_1 422 426 PF00017 0.409
LIG_SH2_SRC 305 308 PF00017 0.458
LIG_SH2_SRC 37 40 PF00017 0.566
LIG_SH2_STAP1 37 41 PF00017 0.542
LIG_SH2_STAT3 128 131 PF00017 0.444
LIG_SH2_STAT3 518 521 PF00017 0.524
LIG_SH2_STAT5 178 181 PF00017 0.410
LIG_SH2_STAT5 305 308 PF00017 0.445
LIG_SH2_STAT5 422 425 PF00017 0.410
LIG_SH2_STAT5 450 453 PF00017 0.426
LIG_SH2_STAT5 557 560 PF00017 0.436
LIG_SH2_STAT5 597 600 PF00017 0.477
LIG_SH3_3 98 104 PF00018 0.479
LIG_TYR_ITIM 563 568 PF00017 0.397
LIG_UBA3_1 538 542 PF00899 0.546
LIG_WRC_WIRS_1 317 322 PF05994 0.410
MOD_CDK_SPxxK_3 420 427 PF00069 0.410
MOD_CK1_1 153 159 PF00069 0.521
MOD_CK1_1 168 174 PF00069 0.518
MOD_CK1_1 249 255 PF00069 0.426
MOD_CK1_1 60 66 PF00069 0.677
MOD_CK1_1 88 94 PF00069 0.578
MOD_CK2_1 137 143 PF00069 0.490
MOD_CK2_1 204 210 PF00069 0.407
MOD_CK2_1 464 470 PF00069 0.410
MOD_CK2_1 86 92 PF00069 0.529
MOD_Cter_Amidation 481 484 PF01082 0.426
MOD_Cter_Amidation 497 500 PF01082 0.503
MOD_GlcNHglycan 155 158 PF01048 0.481
MOD_GlcNHglycan 183 186 PF01048 0.412
MOD_GlcNHglycan 187 190 PF01048 0.444
MOD_GlcNHglycan 210 214 PF01048 0.530
MOD_GlcNHglycan 227 230 PF01048 0.424
MOD_GlcNHglycan 309 313 PF01048 0.556
MOD_GlcNHglycan 7 10 PF01048 0.686
MOD_GSK3_1 133 140 PF00069 0.446
MOD_GSK3_1 181 188 PF00069 0.417
MOD_GSK3_1 200 207 PF00069 0.274
MOD_GSK3_1 214 221 PF00069 0.369
MOD_GSK3_1 246 253 PF00069 0.400
MOD_GSK3_1 291 298 PF00069 0.424
MOD_GSK3_1 460 467 PF00069 0.451
MOD_GSK3_1 5 12 PF00069 0.696
MOD_GSK3_1 555 562 PF00069 0.542
MOD_GSK3_1 587 594 PF00069 0.492
MOD_N-GLC_1 99 104 PF02516 0.557
MOD_NEK2_1 144 149 PF00069 0.403
MOD_NEK2_1 299 304 PF00069 0.463
MOD_NEK2_1 460 465 PF00069 0.485
MOD_NEK2_1 509 514 PF00069 0.448
MOD_NEK2_1 555 560 PF00069 0.426
MOD_NEK2_1 587 592 PF00069 0.478
MOD_NEK2_1 71 76 PF00069 0.513
MOD_NEK2_2 150 155 PF00069 0.528
MOD_NEK2_2 295 300 PF00069 0.429
MOD_NEK2_2 78 83 PF00069 0.528
MOD_PIKK_1 200 206 PF00454 0.546
MOD_PKA_1 499 505 PF00069 0.613
MOD_PKA_2 218 224 PF00069 0.462
MOD_PKA_2 349 355 PF00069 0.410
MOD_PKA_2 460 466 PF00069 0.450
MOD_PKA_2 499 505 PF00069 0.571
MOD_Plk_1 200 206 PF00069 0.546
MOD_Plk_2-3 268 274 PF00069 0.542
MOD_Plk_4 254 260 PF00069 0.449
MOD_Plk_4 464 470 PF00069 0.410
MOD_Plk_4 57 63 PF00069 0.640
MOD_Plk_4 78 84 PF00069 0.482
MOD_ProDKin_1 100 106 PF00069 0.477
MOD_ProDKin_1 420 426 PF00069 0.410
MOD_SUMO_rev_2 210 217 PF00179 0.448
MOD_SUMO_rev_2 279 287 PF00179 0.512
TRG_DiLeu_BaEn_4 72 78 PF01217 0.496
TRG_DiLeu_BaLyEn_6 395 400 PF01217 0.439
TRG_DiLeu_BaLyEn_6 437 442 PF01217 0.546
TRG_ENDOCYTIC_2 111 114 PF00928 0.426
TRG_ENDOCYTIC_2 155 158 PF00928 0.410
TRG_ENDOCYTIC_2 37 40 PF00928 0.484
TRG_ENDOCYTIC_2 422 425 PF00928 0.397
TRG_ENDOCYTIC_2 47 50 PF00928 0.443
TRG_ENDOCYTIC_2 560 563 PF00928 0.397
TRG_ENDOCYTIC_2 565 568 PF00928 0.397
TRG_ER_diArg_1 2 4 PF00400 0.651
TRG_ER_diArg_1 28 31 PF00400 0.477
TRG_ER_diArg_1 610 612 PF00400 0.429
TRG_Pf-PMV_PEXEL_1 22 27 PF00026 0.600
TRG_Pf-PMV_PEXEL_1 390 395 PF00026 0.442

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N0P3D6 Leptomonas seymouri 76% 99%
A0A0S4IUT5 Bodo saltans 63% 87%
A0A0S4JQE6 Bodo saltans 53% 97%
A0A1X0NQM6 Trypanosomatidae 65% 100%
A0A1X0P5J1 Trypanosomatidae 25% 100%
A0A3S5H5T1 Leishmania donovani 26% 100%
A0A422NKY7 Trypanosoma rangeli 61% 100%
A4H4Q0 Leishmania braziliensis 27% 100%
A4H4Q2 Leishmania braziliensis 27% 100%
A4HGV3 Leishmania braziliensis 89% 100%
A4HMU0 Leishmania braziliensis 25% 100%
A4HSY0 Leishmania infantum 26% 100%
A4I3Y3 Leishmania infantum 100% 100%
D0A954 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 45% 100%
E9AKW6 Leishmania mexicana (strain MHOM/GT/2001/U1103) 26% 100%
E9B073 Leishmania mexicana (strain MHOM/GT/2001/U1103) 96% 100%
O53666 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) 31% 100%
P15650 Rattus norvegicus 26% 100%
Q0AVA8 Syntrophomonas wolfei subsp. wolfei (strain DSM 2245B / Goettingen) 29% 100%
Q0AVM4 Syntrophomonas wolfei subsp. wolfei (strain DSM 2245B / Goettingen) 32% 100%
Q3L887 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) 31% 100%
Q4Q812 Leishmania major 97% 100%
Q4QIY9 Leishmania major 26% 100%
Q5LLW7 Ruegeria pomeroyi (strain ATCC 700808 / DSM 15171 / DSS-3) 38% 100%
V5DCV2 Trypanosoma cruzi 63% 100%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS